124 related articles for article (PubMed ID: 3147927)
21. Effects of transdermal 17 beta-estradiol treatment and naloxone infusion on gonadotropin response to gonadotropin-releasing hormone in postmenopausal women.
Cagnacci A; Melis GB; Paoletti AM; Soldani R; Fioretti P
J Clin Endocrinol Metab; 1990 Feb; 70(2):365-70. PubMed ID: 2105330
[TBL] [Abstract][Full Text] [Related]
22. Pulsatile GnRH stimulates normal cyclic ovarian function in amenorrheic lactating postpartum women.
Zinaman MJ; Cartledge T; Tomai T; Tippett P; Merriam GR
J Clin Endocrinol Metab; 1995 Jul; 80(7):2088-93. PubMed ID: 7608260
[TBL] [Abstract][Full Text] [Related]
23. Serotoninergic control of gonadotrophin and prolactin secretion in women.
Ulrich U; Nowara I; Rossmanith WG
Clin Endocrinol (Oxf); 1994 Dec; 41(6):779-85. PubMed ID: 7889614
[TBL] [Abstract][Full Text] [Related]
24. The effect of naloxone on endogenous opioid regulation of pituitary gonadotropins and prolactin during the menstrual cycle.
Snowden EU; Khan-Dawood FS; Dawood MY
J Clin Endocrinol Metab; 1984 Aug; 59(2):298-302. PubMed ID: 6330154
[TBL] [Abstract][Full Text] [Related]
25. The interaction of gonadotropin-releasing hormone and estradiol on luteinizing hormone and prolactin gene expression in female hypogonadal (hpg) mice.
Saade G; London DR; Clayton RN
Endocrinology; 1989 Apr; 124(4):1744-53. PubMed ID: 2538310
[TBL] [Abstract][Full Text] [Related]
26. Effect of luteal metoclopramide-induced hyperprolactinemia on pituitary and luteal responsiveness to gonadotropin-releasing hormone.
Caruso A; Lanzone A; Fulghesu AM; Apa R; Guida C; Mancuso S
Horm Res; 1989; 31(4):169-74. PubMed ID: 2507435
[TBL] [Abstract][Full Text] [Related]
27. Abnormal patterns of pulsatile luteinizing hormone secretion in women with hyperprolactinemia and amenorrhea: responses to bromocriptine.
Sauder SE; Frager M; Case GD; Kelch RP; Marshall JC
J Clin Endocrinol Metab; 1984 Nov; 59(5):941-8. PubMed ID: 6434588
[TBL] [Abstract][Full Text] [Related]
28. Gonadotropin and prolactin pulsations in hyperprolactinemic women before and during bromocriptine therapy.
Klibanski A; Beitins IZ; Merriam GR; McArthur JW; Zervas NT; Ridgway EC
J Clin Endocrinol Metab; 1984 Jun; 58(6):1141-7. PubMed ID: 6427260
[TBL] [Abstract][Full Text] [Related]
29. Neuroendocrine aberrations in women with functional hypothalamic amenorrhea.
Berga SL; Mortola JF; Girton L; Suh B; Laughlin G; Pham P; Yen SS
J Clin Endocrinol Metab; 1989 Feb; 68(2):301-8. PubMed ID: 2493024
[TBL] [Abstract][Full Text] [Related]
30. Hormone ontogeny in the ovine fetus: XIV. The effect of 17 beta-estradiol infusion on fetal plasma gonadotropins and prolactin and the maturation of sex steroid-dependent negative feedback.
Gluckman PD; Marti-Henneberg C; Kaplan SL; Grumbach MM
Endocrinology; 1983 May; 112(5):1618-23. PubMed ID: 6403330
[TBL] [Abstract][Full Text] [Related]
31. Thyrotropin-releasing hormone and gonadotropin-releasing hormone test to predict effectiveness of bromocriptine therapy in infertile women.
Lin KC; Okamura H; Koshida M; Mori T
Fertil Steril; 1986 Nov; 46(5):846-51. PubMed ID: 3096783
[TBL] [Abstract][Full Text] [Related]
32. [Behavior of basal and stimulated serum levels of prolactin, growth hormone and gonadotropins in females with chronic uremia].
Rudolf K; Rudolf H; Rüting M; Falkenhagen D
Z Gesamte Inn Med; 1988 Oct; 43(19):542-4. PubMed ID: 3145648
[TBL] [Abstract][Full Text] [Related]
33. Effects of bromocriptine and naloxone on plasma levels of prolactin, LH and FSH during suckling in the female rat: responses to gonadotrophin releasing hormone.
Sirinathsinghji DJ; Martini L
J Endocrinol; 1984 Feb; 100(2):175-82. PubMed ID: 6420492
[TBL] [Abstract][Full Text] [Related]
34. Chronic hyperestrogenemia: lack of positive feedback action on gonadotropin-releasing hormone-induced luteinizing hormone release and dual site of negative feedback action.
Richardson DW; Gordon K; Billiar RB; Little AB
Endocrinology; 1992 Mar; 130(3):1090-6. PubMed ID: 1537275
[TBL] [Abstract][Full Text] [Related]
35. Catecholamines and pituitary function. I. Effects of catecholamine synthesis inhibition and subsequent catecholamine infusion on gonadotropin and prolactin serum levels in normal cycling women and in women with hyperprolactinemic amenorrhea.
Nicoletti I; Filipponi P; Sfrappini M; Fedeli L; Petrelli S; Gregorini G; Santeusanio F; Brunetti P
Horm Res; 1984; 19(3):158-70. PubMed ID: 6425187
[TBL] [Abstract][Full Text] [Related]
36. Estrogenic modulation of the gonadotropin-releasing hormone-stimulated secretory activity of the gonadotrope and lactotrope in prepubertal females with Turner's syndrome.
Mauras N; Rogol AD; Veldhuis JD
J Clin Endocrinol Metab; 1991 Dec; 73(6):1202-9. PubMed ID: 1955502
[TBL] [Abstract][Full Text] [Related]
37. Gonadotropin and prolactin secretion increases during sleep during the puerperium in nonlactating women.
Liu JH; Park KH
J Clin Endocrinol Metab; 1988 Apr; 66(4):839-45. PubMed ID: 3126216
[TBL] [Abstract][Full Text] [Related]
38. Influence of blindness on plasma luteinizing hormone, follicle-stimulating hormone, prolactin, and testosterone levels in prepubertal boys.
Bellastella A; Criscuolo T; Sinisi AA; Iorio S; Mazzuca A; Parlato F; Perrone L; Faggiano M
J Clin Endocrinol Metab; 1987 Apr; 64(4):862-4. PubMed ID: 3102549
[TBL] [Abstract][Full Text] [Related]
39. Naloxone increases the frequency of pulsatile luteinizing hormone secretion in women with hyperprolactinemia.
Cook CB; Nippoldt TB; Kletter GB; Kelch RP; Marshall JC
J Clin Endocrinol Metab; 1991 Nov; 73(5):1099-105. PubMed ID: 1939525
[TBL] [Abstract][Full Text] [Related]
40. Corpus luteum insufficiency induced by a rapid gonadotropin-releasing hormone-induced gonadotropin secretion pattern in the follicular phase.
Soules MR; Clifton DK; Bremner WJ; Steiner RA
J Clin Endocrinol Metab; 1987 Sep; 65(3):457-64. PubMed ID: 3114301
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
